Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
3,711,486
-
Shares change
-
+124,279
-
Total reported value, excl. options
-
$17,439,623
-
Value change
-
-$1,951,584
-
Put/Call ratio
-
1.32%
-
Number of buys
-
21
-
Number of sells
-
-20
-
Price
-
$4.7
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2017
62 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2017.
XBiotech Inc. - Common Shares, no par value (XBIT) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,711,486 shares
of 33,289,095 outstanding shares and own 11.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,441,941 shares), VANGUARD GROUP INC (785,634 shares), STATE STREET CORP (309,747 shares), NORTHERN TRUST CORP (236,030 shares), GEODE CAPITAL MANAGEMENT, LLC (162,613 shares), GOLDMAN SACHS GROUP INC (80,254 shares), Bank of New York Mellon Corp (73,451 shares), A.R.T. Advisors, LLC (50,306 shares), TIAA CREF INVESTMENT MANAGEMENT LLC (43,433 shares), and ALLIANCEBERNSTEIN L.P. (42,800 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.